Detalhe da pesquisa
1.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Blood
; 143(2): 152-165, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832030
2.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Blood
; 140(17): 1845-1857, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917453
3.
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Am J Hematol
; 98(2): 272-281, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309981
4.
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.
Intern Med J
; 53(1): 119-125, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371767
5.
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG.
Biol Blood Marrow Transplant
; 26(10): 1868-1875, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32640314
6.
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Haematologica
; 102(2): 356-363, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143954
7.
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies.
Transplant Cell Ther
; 30(3): 334.e1-334.e7, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029962
8.
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.
Transplant Cell Ther
; 29(6): 383.e1-383.e10, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934993
9.
Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
Blood Adv
; 4(17): 4147-4150, 2020 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886750
10.
The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia.
Leuk Lymphoma
; 60(7): 1796-1802, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632843
11.
'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
Leuk Lymphoma
; 59(6): 1514-1516, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29022836
12.
Utility of FDG-PET for staging in a case of mycosis fungoides.
Dermatology
; 214(2): 185-7, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17341872